Core Viewpoint - A securities class action lawsuit has been filed against Applied Therapeutics, Inc. for alleged misconduct related to its drug candidate, govorestat, during the Class Period from January 3, 2024, to December 2, 2024 [1][3]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Southern District of New York [1]. - The lead plaintiff deadline for investors is set for February 18, 2025 [1][4]. - The complaint alleges that Applied Therapeutics made false or misleading statements and failed to disclose non-compliance with trial protocols, risking FDA rejection of trial data [3]. Group 2: Investor Information - Investors who suffered losses can seek to be appointed as lead plaintiffs or remain absent class members [4]. - The lead plaintiff represents the interests of all class members and selects counsel for the litigation [4]. - Kessler Topaz Meltzer & Check, LLP encourages affected investors to contact them for more information [5].
APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)